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ABSTRACT 
Proper regulation of the cell cycle is essential for genetic stability and function. 
Mutations resulting in deregulation of the cell cycle are attributable to the development of 
diseases such as cancer. A large portion of the proteins responsible for regulating the cell cycle 
are found at DNA replication origins making replication origins an attractive target of research. 
Our lab has previously characterized a replication origin found in the promoter region of the 
human DBF4 locus which contains two zones at which two Origin Recognition Complexes bind 
and initiate replication in opposite directions in a specific manner termed Asymmetrical 
Bidirectional Replication. Within these same zones, our lab has also discovered the presence of 
transcription start sites for long non-coding RNA (lncRNA) transcripts. We’ve found that these 
non-coding transcripts are differentially transcribed from their neighboring genes and are 
resistant to RNA polymerase I, II and III inhibition. Results from these studies unexpectedly 
indicate the possibility of the mitochondrial RNA polymerase acting in the nucleus to transcribe 
the lncRNAs at the DBF4 locus. These transcripts are also cyclically more stably expressed than 
the DBF4 gene while retaining a relatively short half-life. 
In an attempt to achieve a broader understanding of the replication process, the work in 
this thesis presents an effort to characterize and identify these lncRNAs initiating in the DBF4 
promoter region and provide new insights into their behavior.  
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1.0 Introduction 
 
1.1 Background 
DNA replication is the keystone process of the cell that allows for life to replicate itself 
and propagate indefinitely. Any dividing cell must go through a specific sequential set of steps 
which constitutes the cell cycle. The eukaryotic cell cycle is divided into four phases: the G1, S, 
G2 and M phases (Schafer 1998). Most cycling eukaryotic cells spend the majority of the cell 
cycle in the first gap phase, G1, which is a period of growth and general preparation for progress 
into S phase. The beginning of S phase, or synthesis phase, is marked by the initiation of DNA 
replication and ends once the cell has produced the entire copy of its own genome. The G2 
phase, a shorter gap phase, then follows and the cell continues to produce organelles and other 
cellular constituents until it is ready to divide. Finally, the M phase is the shortest and most 
complex phase where mitosis occurs; the duplicated DNA is segregated and cells divide in a way 
that assures both daughter cells will have a full copy of the original genome (Schafer 1998). 
Quiescent cells remain either temporarily or permanently in the G0 phase and behave like an 
extended G1 phase, except they typically do not grow in size or produce extra organelles in 
preparation for the next cell division (Blagosklonny 2006). 
 
1.1.1 The Mechanism of Cell Cycle Control 
The eukaryotic cell cycle is largely governed by the cyclins. Cyclins are cyclically 
expressed proteins that are degraded in a strictly regulated sequence which assures that cells 
progress in a single direction through the cell cycle in a clockwork manner (Johnson & Walker 
1999). Cyclins form complexes with cyclin-dependent kinases (cdks). Cdks are serine-threonine 
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kinases that, when bound to different cyclins, phosphorylate various key proteins responsible for 
activating various cell cycle-related tasks. 
 A large portion of the cell machinery is devoted to assuring that DNA replication 
initiates in a timely and accurate manner to ensure faithful replication only once per cell cycle 
(Arias & Walter 2007). Cell cycle regulation is accomplished through the form of checkpoints 
working in conjunction with the cyclins. Different checkpoints monitor different parts of the cell 
cycle and, when activated, they prevent further progression into the cell cycle until the source 
that triggered the checkpoint has been addressed (Elledge 1996; Johnson & Walker 1999). If an 
actively cycling cell is held for an extended period of time outside of the G1 phase, indicating an 
inability to rectify the problem in a timely manner, the transcription factor p53 triggers 
downstream targets eventually leading to the release of active caspases into the cytoplasm 
resulting in cell death via apoptosis (Elmore 2007).  
Defects among the multiple safeguards that prevent abnormal replication are crucial for 
the transition from normal to cancerous cells, making the mechanics of DNA replication an 
attractive target of cancer research (Kastan & Bartek 2004). A large portion of this regulation 
ultimately influences the proteins associated with replication origins – sites at which DNA 
replication and cell cycle regulating proteins gather and assemble and begin the process of 
copying DNA when the cell is ready for cell division (Méchali 2010). 
 
1.1.2 Replication origins 
The replication origins of prokaryotes, and simple eukaryotes such as budding yeast, are 
defined by specific consensus sequences signaling precisely where replication origins are located 
within their genome (Méchali 2010). Mammalian replication origins are also organized at 
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specific sites throughout genomic DNA, however these sites are more flexible and loosely 
defined. The lack of consensus sequences for replication origins in most eukaryotes has made it 
difficult to locate and study them as there is still no method to reliably predict where one of these 
replication origins is located (Gilbert 2001). 
Until recently, only about 30 mammalian origins had been found (reviewed by Aladjem 
et al. 2006). In the past few years however, recent advances in genome wide replication mapping 
have uncovered the loci of a large quantity (nearly 14,000) of replication origins in humans 
(Dellino et al. 2013). It is estimated that to copy the 3,300 megabases of human genomic DNA 
during the typical 5-6 hour S phase window, 30,000-50,000 active replication origins must fire 
during every cell cycle, indicating that there are still many origins to be found and characterized 
(Méchali 2010). Furthermore, only a couple of the mammalian origins, specifically the origins 
found at the DBF4 and Lamin B2 loci, have been described in-depth at the single nucleotide level 
as there are only a few methods available to study mammalian origins in detail. The first method 
is the more tedious ligation-mediated PCR method used to characterize the Lamin B2 origin 
(Abdurashidova et al. 2000) and the other is replication initiation point (RIP) mapping technique 
developed in our lab to study the origin at DBF4 (Romero & Lee 2008b).  Currently, neither 
method has been adapted for high throughput analysis of replication origins, preventing large 
scale studies of known replication origins at high resolution. 
The DBF4 gene, located on human chromosome 7, codes for the DBF4 protein which is a 
key regulator of cell-cycle progression. DBF4, or dumbbell forming factor 4, is named for the 
characteristic dumbbell shape observed in cells when this protein undergoes a loss of function 
mutation in yeast and is also known as Activator of S phase Kinase (ASK). There is also a DBF4 
pseudogene located on chromosome 10. A pseudogene is a non-functional copy of a gene found 
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elsewhere on the genome likely due to an abnormal chromosomal duplication event resulting in 
the generation of non-functional gene segments. Alternatively, pseudogenes may also arise from 
a retrotransposition, where RNA strands are randomly reverse transcribed into DNA by a reverse 
transcriptase and, by chance, subsequently inserted into the genome. As the DBF4 pseudogene 
lacks the intronic sequences and promoter sequence from the original gene, it would most likely 
have been created by a retrotransposition event. The DBF4 pseudogene is also devoid of a 
replication origin such as the one found at the DBF4 locus. The pseudogene sequence also lacks 
the entire 11th exon of the original DBF4 gene. Apart from the missing exon, however, the rest of 
the DBF4 pseudogene is nearly identical in sequence to the exonic region of DBF4 resulting in 
important considerations when choosing PCR primers to study the DBF4 region. 
DBF4 protein levels increase and stabilize at the G1/S transition and remain high until the 
end of S phase (Kumagai et al. 1999). When DBF4 protein levels are high, it forms a complex 
with Cdc7 which activates Cdc7 kinase functions in a manner analogous to cyclin-Cdk 
complexes. The active Cdc7-DBF4 complex tethers itself to the pre-RC complex and 
phosphorylates MCM proteins, activating the helicase function of the MCM complex, and is the 
final step to signaling cells to begin copying DNA in S phase (Jiang et al. 1999). Cdc7 protein 
levels remain constant throughout the cell cycle; however, its activity is dependent on DBF4 
protein levels (Kumagai et al. 1999). 
The Origin Recognition Complex (ORC) is a 6-subunit protein complex that can bind to 
many regions of DNA, marking them as potential replication origins (DePamphilis 2003). In late 
M/early G1, chromatin-bound ORC recruits Cdc6 to an origin which subsequently recruits Cdt1 
and the MCM helicase complex (Bell & Dutta 2002). Together, these proteins form the pre-
replication complex (pre-RC). Multiple factors appear to be involved in determining the regions 
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that ORCs will target. At the beginning of S phase, Cdc6 is phosphorylated and degraded and 
Cdt1 is inhibited by Geminin (Ballabeni et al. 2004). When cells are ready to progress into the S-
phase, Cdc7-DBF4 phosphorylates multiple subunits of the MCM complex leading to the 
activation of its helicase activity (Weinreich & Stillman 1999; Jiang et al. 1999). The rest of the 
replisome is then recruited and DNA replication begins.  
Only a portion of ORC-bound origins fire in a given cell cycle (Rhind 2006). Some origins 
fire consistently across all cell types within a species while firing of others varies greatly. 
Furthermore, after the onset of S-phase, certain origins fire almost immediately (early-firing 
origins) while others don’t begin replicating DNA until later during S phase (late-firing origins) 
(Méchali 2010). It has been thought that different configurations in heterochromatin as well as 
the position of DNA within the nucleus across various cell types contributes to the variation in 
location and timing of active origins (Vogelauer et al. 2002), although the exact regulatory 
mechanism responsible is not well understood. 
Our lab has previously shown that the DBF4 locus contains an early-firing replication origin 
in its promoter region and with two ORC-binding sites. What is particular about this origin, is 
that it contains two initiation zones that fire sequentially in opposite directions in a precisely 
coordinated manner (Romero & Lee 2008a) (Figure 1), a process termed Asymmetrical 
Bidirectional Replication (ABR). This process is different from the previously studied Origin of 
Bidirectional Replication (OBR) model,  characterized at the human lamin B2 locus, in which 
replication was observed to initiate from a single point and extend in both directions at once 
(Burhans et al. 1990). However, when using the RIP-mapping technique on the lamin B2 origin, 
our lab found that the lamin B2 origin also has a similar gap between replication initiation points 
in each direction, suggesting that the lamin B2 origin follows the ABR  
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Figure 1. Map of the ABR origin at the DBF4 locus 
 
 
 
 
A map of the DBF4 promoter region located on chromosome 7. The first two exons of 
the DBF4 and SLC25a40 genes are depicted. The promoter of DBF4 is located within the 
indicated boxed region and the core promoter is colored in grey. In the ABR model, DNA 
replication begins first from multiple sites located within initiation zone 1 into the same 
direction of DBF4 transcription and afterwards DNA replication begins on the other 
DNA strand within initiation zone 2 traveling in the opposite direction. Each zone 
contains its own set of ORCs and replication proteins. The ladder indicates base positions 
relative to the ATG (A is +1) sequence of the DBF4 coding region. 
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model (Lee & Romero 2012). Another study on the II/9A origin of Sciara coprophillia also 
found a similar separation between replication initiation points (Bielinsky et al. 2001) adding 
further support to the prevalence of the ABR model in eukaryotic cells. 
 
1.2.1 Long non-coding RNA (lncRNA) 
The most well-known role of RNA is its role as a messenger, carrying information 
transcribed from DNA that can be read and translated into proteins by the ribosomes. However, 
the majority of RNA is non-coding: this includes the 20 or so transfer RNA (tRNA), the 3 major 
ribosomal RNAs (rRNA), a variety of ribonucleoproteins and a large number of mRNA of 
various sizes which do not code for proteins. tRNAs and rRNAs were originally thought to be 
exceptions to RNA’s role as a messenger. RNA whose sequences were found to lack proper open 
reading frames that can code for protein were once disregarded as corresponding to non-
functional by-products of gene transcription that would be eventually degraded by RNAses and 
recycled for more transcription (Mercer et al. 2009). More recently, however, it has been shown 
that a large portion of these non-coding transcripts are in fact functional and often associate with 
proteins allowing them to target various processes in the cell (Mercer et al. 2009). It is currently 
unclear if most non-coding RNAs (ncRNAs) are functional. However, the list of ncRNAs 
associated with functions is growing rapidly as effective techniques for determining targets of 
ncRNAs are now available (Mercer et al. 2009). 
ncRNAs are classified based on their size (e.g. long non-coding RNA, microRNA), 
cellular location (small nucleolar RNA, piwi associate RNA), function (small interfering RNA), 
shape (short hairpin RNAs) or even location on DNA (long intergenic ncRNA, antisense 
lncRNA) (Ma et al. 2013). Among these classifications, long non-coding RNA (lncRNA) is a 
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relatively vague class of RNAs as it encompasses all ncRNAs over 200 bases in size. This 
minimum length is somewhat arbitrary which is based on the differences in techniques in 
isolating different size ranges and there is much overlap in function between ncRNAs and 
lncRNAs. 
RNA is capable of forming DNA-RNA triplexes with double-stranded genomic DNA as 
well as DNA-RNA hybrid molecules or RNA-RNA duplexes forming secondary and tertiary 
structures that allow them to take on various functional shapes and be recognized by proteins 
(Mercer et al. 2009). This provides an interface for proteins bound to ncRNAs and allows them 
to target DNA or RNA sequences within the cell with high sequence specificity. The same 
protein is able to recognize different targets depending on the ncRNA it is bound to which 
permits more variety in targets that bind to a single protein. Many lncRNAs have been 
implicated recruiting chromatin modifying enzymes to DNA (Mercer et al. 2009). The well-
known Xist lncRNA coats the inactive X chromosome and recruits chromatin-modifying 
enzymes that recognize Xist and silence the X chromosome from which Xist is transcribed 
(Chow et al. 2005). Other lncRNAs are also able to recruit chromatin modifying enzymes 
throughout the genome acting as epigenetic regulators (Lee 2012). 
LncRNAs regulate transcription activators and repressors, as well as RNA polymerase II 
(RNAP II), providing yet another level of transcriptional regulation (Goodrich & Kugel 2006). 
Additionally, genes are regulated by lncRNAs with hairpin structures which can be cleaved into 
smaller fragments by DICER and subsequently used as small interfering RNA (siRNA). SiRNAs 
bound to the RNA-induced silencing complex (RISC) act as a template to target other 
complimentary transcripts to be degraded thereby reducing the transcript pool for individual 
proteins (Tijsterman & Plasterk 2004). Furthermore, the act of transcription of lncRNAs can 
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simply affect nearby genes by opening up chromatin to allow easier access for transcription 
factors to bind to regulatory regions of other genes or to compete for the same regulatory region 
(Magdalou et al. 2014). 
 
1.2.2 RNA transcription 
There are 4 known RNA polymerases found in the mammalian system. Each of the 
mammalian RNA polymerazes recognize different sets of DNA sequences with the aid of 
various transcription factors allowing them to transcribe specific RNA products. RNA 
polymerase I (RNAP I) is responsible for transcribing the sequences for the 5.8S, 18S and 28S 
ribosomal RNAs (rRNAs) (Drygin et al. 2010). RNAP I is located uniquely to the nucleolus 
where it transcribes the rRNAs which are subsequently cleaved during post-translational 
modifications to generate the three individual rRNA molecules. The human genome contains 
hundreds of copies of the rRNA gene transcribed by RNAP I. Despite the low number of RNAP 
I targets, they are the most actively transcribed genes and constitute approximately 80% of total 
cellular RNA (Drygin et al. 2010). 
RNAP II is responsible for the transcription of the protein-encoding mRNAs in the 
nucleus as well as most ncRNAs (and lncRNAs) (Hahn 2004). This polymerase is distinguished 
by its C-terminal tail on its largest subunit, where many proteins necessary for processing RNAP 
II-transcribed RNAs reside (Phatnani & Greenleaf 2006). Among these proteins are 
methyltransferases, which are responsible for capping RNAP II products with guanine at the 5’ 
end. The 5’ guanine cap is essential in providing degradation resistance to mRNAs from 
cytosolic proteins that degrade RNA and is also important for mRNA transport and translation 
(i.e., RNases) (Cho et al. 1997). Another feature of RNAP II products not found with RNAP I or 
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III is that they have a poly-A tail which consists of multiple repeats of adenine at the 3’ end of its 
RNA products (Eggermont & Proudfoot 1993). These poly-A tails add additional stability to 
mRNAs. As poly-A tails are degraded over time in the cytosol, the coding regions on the Mrna 
are eventually exposed and are degraded resulting in a non-functional transcript (Slomovic et al. 
2010). Another notable protein complex that associates with the RNAP II C-terminal tail is the 
spliceosome, which is responsible for removing  introns from RNAP II-transcribed mRNA (Will 
& Lührmann 2011). 
Similar to RNAP I, RNAP III is involved in the transcription of a narrow spectrum of 
RNA species. RNAP III is responsible for the transcription of all tRNAs as well as the 5S rRNA, 
which is the only rRNA not transcribed by RNAP I (White 2011). This polymerase is also 
responsible for transcribing small interspersed nuclear elements (SINEs), one of the most 
abundant elements in the human genome, among other ncRNA and lncRNA (Cordaux & Batzer 
2009). 
Lastly, the mitochondrial RNA polymerase (MtRPOL), which is transcribed in the 
nucleus by RNAP II, is thought to be exclusively located to the mitochondria where it transcribes 
all of the mitochondrial DNA (Arnold et al. 2012). However, some recent studies indicated that 
MtRPOL, or perhaps a truncated version named spRNAP-IV, may localize to the nucleus. This 
nuclear form of MtRPOL is reported to transcribe some genes in the nucleus including ALDH8 
(Kravchenko et al. 2005) as well as a number of muscle actin genes (Lee et al. 2011). There has 
been very little follow-up on the potential nuclear activities of MtRPOL and it is not known how 
a nuclear MtRPOL would be able to recognize transcription sites on chromatin which, unlike 
mitochondrial RNA, is more tightly packed with histones and other proteins. Most recently, 
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however, it has been suggested that MtRPOL does not locate in the nucleus or transcribe ALDH8 
(Kühl et al. 2014). 
Many groups have noted a possible interplay between transcription and replication 
cellular machinery, as both of these processes must physically cross paths on DNA when the 
duplication of the cell’s genetic content is under way (Schneider & Grosschedl 2007; Giri & 
Prasanth 2012). Interestingly, our lab has previously noted that DBF4 transcription levels 
temporarily decrease during high replication origin activity and increase after replication in the 
area is complete (Romero 2008). During the process of characterizing the DBF4 replication 
origin we surveyed this region for the presence of non-protein coding transcripts. In this thesis I 
report the presence of multiple lncRNAs located within the two ORC binding sites at the DBF4 
locus. The objectives in this research are to confirm that these lncRNAs are transcriptionally 
different than the DBF4 gene with which it overlaps, to determine which RNA polymerase is 
responsible for transcribing these lncRNAs and to determine if transcription levels of the 
lncRNAs have an effect on neighbouring genes on the human chromosome. 
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2.0 Materials and Methods 
 
2.1 Cell culture 
HeLa S3 (ATCC CCL-2.2; Manassas, Virginia, USA) cells were cultured in RPMI-1640 
medium containing 10% v/v fetal bovine serum (Hyclone – GE Life Sciences; Mississauga, 
Ontario, Canada). Culture of HEK293T (ATCC CRL-3216) cells was carried out using 
Dulbecco’s modified Eagle’s medium containing 10% v/v fetal bovine serum. Human mammary 
epithelial 184B5 (ATCC CRL-8799) cells were cultured in serum-free, mammary epithelial basal 
medium (MEBM) supplemented with 1 ng/ml cholera toxin, 0.5 g/ml hydrocortisone, 10 ng/ml 
human epidermal growth factor, 5 g/ml insulin, 13 g/ml bovine pituitary extract and 1% v/v 
GA-1000 (gentamicin-amphotericin mix, Lonza, distributed through CEDARLANE; Burlington, 
Ontario, Canada). All cells were incubated in a humidified environment at 37°C with 5% CO2. 
When needed, α-amanitin was aseptically mixed into the media at a concentration of 111 μg/ml. 
 
2.2 Synchronization 
HeLa cells were synchronized at the G1/S border using a double-thymidine block. 
Briefly, asynchronous HeLa cells were incubated in culture medium containing 2 mM thymidine 
(Sigma) for 18 h. Cells were then washed once with 1x PBS pH 7.4 (137 mM NaCl, 2.7 mM 
KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4) and released into culture medium for 11 h. Cells were 
then incubated a second time in regular medium containing 2 mM thymidine for 13.5 h. After 
another wash with PBS pH 7.4, cells were released in culture medium and samples were 
collected at the indicated times for analysis.  
 
 
13 
 
 
2.3 Flow cytometry  
Cell cycle progression was monitored using flow cytometry to measure the DNA content 
of cells. Cells were harvested by trypsinization, washed once with PBS pH 7.4, and fixed by 
incubation in 70% v/v ethanol for at least 18 h at -20°C. The cells were then washed twice with 
PBS pH 7.4 and incubated in propidium iodide staining solution (0.1% w/v sodium citrate, 0.3% 
v/v NP-40, 100 μg/ml propidium iodide, 100 μg/ml RNase A) for >1 h at room temperature. 
Samples were analyzed using a Beckman Coulter FC500 flow cytometer.  
 
2.4 RNA isolation and analysis of RNA using primer extension 
RNA was isolated using a QIAGEN RNeasy Mini kit following the manufacturer’s 
protocol (QIAGEN, Mississauga, Ontario, Canada). RNA concentrations and purity were 
determined by measuring the OD260 and OD280 using the NanoDrop 2000 (Thermo Scientific; 
Ottawa, Ontario, Canada). 5 µg of RNA, 6 µl of 5x first strand buffer (Invitrogen; Burlington, 
Ontario, Canada) and 5 pmol of DIG-labeled primer (Roche; Mississauga, Ontario, Canada. see 
Table 1) were mixed together and RNase-free water was added to a final volume of 23 µl and 
vortexed very lightly. The mixture was then brought to the 65°C annealing temperature for 10 
min and then cooled on ice. 3 µl of 8 mM dNTPs, 3 µl of 0.1 M DTT and 1 µl of Superscript II 
reverse transcriptase (Invitrogen; Burlington, Ontario, Canada) were added to the mixture for a 
final volume of 30 µl. Samples were then incubated for 1 h at 42°C for extension. Once this 
procedure was completed, the reverse transcriptase was denatured by incubating at 90°C for 5 
min, and chilled on ice, followed by the addition of 20 µl formamide gel loading buffer (98% 
formamide; 10% EDTA pH 8.0; 0.1% xylene cyanol; 0.1% bromophenol blue). Samples were 
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heated to 65°C before being added to a 5% w/v acrylamide gel containing 7.7 M urea in 0.5% 
TBE (Tris-borate-EDTA), and the DNA was then separated by PAGE. The DIG-labeled DNA 
molecular weight marker V (Roche; Mississauga, Ontario, Canada) was used alongside samples 
as a size marker. The labeled cDNA was then transferred to a Hybond N+
 
nylon membrane (GE 
Life Sciences; Mississauga, Ontario, Canada) using a semi-dry transfer apparatus. cDNA was 
then fixed to the membrane by exposure to UV light for 6 min. Finally, the extended products 
were detected using a DIG detection kit from Roche (Mississauga, Ontario, Canada). 
 
2.5 Analysis of transcript using RT-qPCR  
qPCR was carried out using a 7900HT ABI Prism thermocycler system (Applied 
Biosystems; Burlington, Ontario, Canada). Reactions were performed in triplicate in a final 
volume of 25 μl containing 12.5 μl of 2× SYBR Green Master Mix (Applied Biosystems; 
Burlington, Ontario, Canada) and 300 nM of each primer (Integrated DNA Technologies; 
Coralville, IA, USA). Primer sequences are shown in Table 1. Standard curves were generated 
for each primer pair using serial dilutions of total genomic DNA (10 ng, 1 ng, 0.1 ng and 0.01 
ng). An equal volume of gel-extracted nascent DNA (usually 2 or 3 μl) was used as template for 
amplification with every primer set. Following initial denaturation for 10 min at 95°C, 
amplification was carried out for 40 cycles as follows: 95°C for 30 s, 59°C for 30 s, and then 
72°C for 30 s. Amplification of a single product of the correct size was verified by melting curve 
analysis and by agarose gel electrophoresis. Relative sequence abundance in a given nascent 
DNA preparation was estimated by calculating the ratio between the amount of each DNA 
segment (as estimated by standard curves) and the amount amplified by the Prom3 primer set in 
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the same DNA sample. Primer pair Prom3 was chosen as a control because it consistently 
showed the lowest levels of amplification.  
 
 
2.6 Determination of transcript half-life 
 The half-life of the DBF4ups (ups for upstream promoter sequence) transcript was studied 
using a Click-iT Nascent RNA Capture Kit (Invitrogen; Burlington, Ontario, Canada). The 
experiment was preformed twice according to the manufacturer’s protocol. Briefly, HeLa cells 
were incubated in regular medium containing ethynyl uridine (EU) for 24h. 0 h samples of total 
RNA were collected immediately after release into fresh medium in the absence of EU (EU-) and 
used as the pre-degradation baseline. A second round of total RNA was collected 24 h after 
release into fresh medium. Total RNA samples were mixed with biotin provided in the kit which 
binds to the labeled RNA. Dynabeads® MyOne™ Streptavidin from the kit were then mixed 
with the total RNA samples and the samples were washed according to manufacturer’s protocol 
to separated labeled RNA from total RNA. Labeled RNA levels between the two samples were 
then analyzed using the 7900HT ABI Prism thermocycler system. As the first attempt generated 
signal near the non-linear edge of the standard curve generated during qPCR, the experiment was 
repeated in triplicate using a 12 h time period instead of 24 h. 
 
2.7 Knockdown of MtRPOL using siRNA 
 Cells were transfected with siRNA using the Lipofectamine 2000 transfection reagent 
(Invitrogen; Burlington, Ontario, Canada) in OptiMEM medium (Life Technologies; Burlington, 
Ontario, Canada). The experiments were preformed according to the manufacturer’s protocol 
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(Invitrogen; Burlington, Ontario, Canada) scaled to 10 cm cell-culture plates. For transfection 
experiments, cultured HEK293T cells were used since the transfection efficiency was generally 
over 90%. SilencerSelect siRNA directed towards MtRPOL (Life Technologies, cat# AM16708) 
was used in this experiment in conjunction with SilencerSelect negative control No. 1. Western 
blot was done to confirm knockdown of MtRPOL using an antibody directed towards MtRPOL 
(cat# SC-365082, Santa Cruz; Dallas, Texas, USA) with antibodies for DBF (cat# ab124707, 
Abcam; Cambridge, Massachussets, USA) 4 and CRM1 (cat# SC-5595, Santa Cruz) used as 
loading controls. 
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3.0 Results 
 
3.1.1 Multiple lncRNA are found surrounding the DBF4 promoter region 
To search for the transcription start sites (TSSs) of transcripts near the promoter region of 
DBF4, primer extension was carried out on total RNA isolated from HeLa cells with digoxigenin 
(DIG) labeled primers. DIG is a steroid isolated from Digitalis sp which can be very specifically 
targeted with an anti-DIG antibody. The antibody is then linked to the chemiluminescent 
substrate CDP-Star, permitting highly sensitive detection of labeled primers without requiring 
PCR to amplify them to obtain detectable bands on a gel. The labeled primers targeted the 5’ 
ends of putative transcripts that can be transcribed in the DBF4 promoter region and were 
extended into cDNA using reverse transcription. The cDNA is a reverse-complement copy of the 
RNA synthesized by reverse transcriptase (RT) starting from where the primer targets (listed in 
Table 1) until the RT enzyme reaches the 5’ end of targeted RNA strand. cDNA synthesis is 
terminated when the RT reaches the end of an RNA strand, producing products of a specific 
length. The cDNA was then resolved by gel electrophoresis, followed by blotting and detection 
(Figure 2A). As there is no PCR amplification, the resulting bands represent directional 
transcripts, preventing accidental detection from antisense targets such as the neighboring 
SLC25a40 gene.  As the sequence of the original primer is mapped to the human genome, the 
rest of the extended 5’ sequence can be deduced based on the size of the products, assuming the 
template RNA is not spliced. 
As can be seen in Figure 2B, Primers pA and pE target the 5’ ends of the RNA 
transcribed in the same direction as DBF4 (primer sequences are found in Table 1). Primer pA 
starts at position -106 (i.e., upstream) relative to the ATG of DBF4 and is thus able to detect the  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Multiple lncRNAs were detected at the DBF4 locus  
A. Primer extension was used to detect lncRNA in the DBF4 promoter locus. The position 
of the most prominent bands relative to the ATG start codon of the DBF4 gene have been 
labeled to the right while the molecular size markers are listed on the far left. In bold 
under the pA primer are the major transcription start sites of the DBF4 mRNA and as 
expected their expression levels were greatly reduced in the presence of RNA polymerase 
inhibitor. pA and PE target transcripts that are sense to the DBF4 gene while pC targets 
transcripts antisense to DBF4. A high exposure is shown to visualize the lower-sized 
bands. 
B. The map constructed with data obtained from Panel A indicating the 5’ ends of the 
lncRNAs as determined using primer extension. The transcription start sites shown are 
mapped assuming that the detected portion of the transcripts were not spliced. The start 
positions of exon 1 of DBF4 and SLC25a40 and the end position of SLC25a40’s exon are 
indicated. Two PCR primers were used for DBF4ups detection: Prom C7UC which 
amplifies the -640 to -703 region and Prom 7B which targets -625 to -675. These primers 
were chosen because neither of them locate within SLC25a40 exons. DIG-labeled 
primers for primer extension as well as PCR primer sets that target the lncRNAs are also 
shown. All distance values are relative to the ATG (+1) of the DBF4 translational start 
site. 
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Table 1. Digoxigenin-labeled primers used to detect the 5’ end of lncRNAs 
Oligo Sequence (5’-3’) 
Size 
(bases) 
% GC 
Position to 
ATG 
Tm 
(°C) 
pA CTTCCGCCAGCTACGGCCTC (S) 20 70.0 -106 to -125 68 
pC 
GCGTAGAGGCCGTAGCTGGC 
(AS) 
20 70.0 -130 to -111 68 
pE AGGTTGTGTTTCCGCCTCTAC (S) 21 52.4 -402 to -422 64 
GAPDH CCATGTAGTTGAGGTCAATG 20 45.0 n/a 58 
chr10a 
GAGTGAACATTCTGAGATTTAT 
(AS) 
22 31.8 -556 to -535 50 
chr10b GGAGTCTTATATGAACTTATG (S) 21 33.3 -609 to -629 46 
chr10c 
GGCAGAAAATCTAAACCATTGA 
(S) 
22 36.4 -334 to -355 58 
 
Primers are labeled with digoxigenin at the 5’ end. The indicated positions of primers pA, pC 
and pE relative to the ATG sequence of DBF4. The indicated positions of ch10a, ch10b and 
ch10b are relative to the ATG sequence of the DBF4 pseudogene. Primers are indicated whether 
they target sense (S) or antisense (AS) direction to DBF4 or the DBF4 pseudogene 
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DBF4 transcription start sites (TSSs) located -215 and -235 from the ATG. Primer pE targets 
sense transcripts further distally from the DBF4 TSS at -402 allowing for better resolution of the 
DBF4ups transcripts. Primer pC is complimentary to the 5’ ends that would be transcribed 
antisense to DBF4. The resulting blot reveals the presence of the TSSs for the DBF4 gene (-215 
and -235) (Figure 2A). Furthermore, several bands were observed indicating the presence of 
TSSs upstream to the DBF4 gene transcript between -500 and -850 bases from the DBF4 ATG 
sequence. These DBF4 upstream transcripts (DBF4ups) were not sensitive to treatment with the 
RNAP II inhibitor α-amanitin (Figure 2A and Figure 3). LncRNAs were also observed between 
+100 and +400 in the antisense direction to the DBF4 gene (DBF4as) with the use of primer pC, 
which were resistant to α-amanitin. Several other transcripts even further from the ATG 
sequence in both directions were detected, however these larger-sized transcripts displayed 
sensitivity to α-amanitin, suggesting that these sequences are not of the same nature as the 
DBF4ups transcripts and the DBF4as transcripts. Figure 2B summarizes the directions, relative 
strengths and putative locations of the detected α-amanitin-insensitive lncRNA transcripts. 
 
3.2.1 LncRNAs in the DBF4 promoter region are differentially transcribed from 
neighboring genes 
A common feature of transcribed RNA is the presence of splice sites – regions of RNA 
that are cut out from newly-synthesized mRNA sequences during, or shortly after, the 
transcription process. Splicing results in discontinuous regions of DNA being represented in the 
final transcripts (e.g., mRNA). While primer extension experiments yield bands corresponding to 
the distance from TSSs for the targeted RNA segments, it does not indicate if these bands 
correspond to a continuously-transcribed sequence of the DBF4 region or if splice sites are found 
within the RNA segment as the extended RNA sequence is still unknown. Furthermore, a single 
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gene such as DBF4 may have alternate splice sites that are not always spliced. Alternative splice 
sites result in multiple variants of RNA species from a defined region of the genome, often 
producing non-protein-coding RNA products alongside its coding counterpart (Luco & Misteli 
2011). 
To differentiate whether the DBF4ups transcripts are indeed novel lncRNAs or if they are 
simply alternate transcripts of DBF4, HeLa cells were treated with the RNA polymerase II (Pol 
II) inhibitor α-amanitin for 20 h. DBF4 is transcribed by Pol II and its expression levels should 
therefore be sensitive to Pol II inhibitors. Using DIG-labeled primer extension, I observed that 
the DBF4ups lncRNAs (Figure 3A) and the DBF4as lncRNAs (Figure 3, primer pC) showed 
comparable, and possibly increased, signal levels when compared to the non-treated control. 
When targeting the DBF4ups region (primers targeting -675 to -625 from the DBF4 TSS) using 
conventional PCR, the same trend can be seen (Figure 3B). The lack of apparent reduction in 
lncRNA level suggests that the DBF4ups and DBF4as transcripts are not transcribed by RNAP II. 
In contrast, the Pol II-transcribed GAPDH and DBF4 genes were reduced in expression levels by 
20 h post-treatment. The SLC25a40 gene, located immediately upstream and antisense to DBF4, 
also showed reduced expression levels in the presence of α-amanitin (Figure 3B), indicating that 
the lncRNAs detected are not products of alternate transcription of SLC25a40. Table 2 shows the 
list of primers used for all conventional PCR and qPCR experiments. 
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Figure 3. RNAP II inhibitor α-amanitin does not reduce DBF4ups expression levels 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A. HeLa cells were treated with 111 µg/mL α-amanitin for 10 or 20 h to determine if 
lncRNA was transcribed by RNAP II. Primer extension was carried out using total RNA 
from treated (+ama) and non-treated (unt) samples with DIG-labeled primers mapping to 
the DBF4 TSS as well as the RNAP II-transcribed GAPDH gene. Bands corresponding to 
the TSSs for GAPDH and DBF4 exhibited downregulation by 20 h post-treatment. 
Conversely, the band corresponding to the DBF4ups transcripts (shown is the -752 start 
site) had stronger signal intensity in the α-amanitin treated sample. Primer sequences are 
indicated in Table 1 
B. Total RNA from HeLa cells treated with 111 µg/mL α-amanitin were also analyzed using 
RT-PCR to confirm the accuracy of the primer extension method. In accordance with 
primer extension, primers mapping the first exon of DBF4 and SLC25a40 (DBF4ex1 and 
SLC25a40ex1 respectively) as well as GAPDH were all downregulated in the presence of 
α-amanitin. The primer mapping the DBF4ups region between SLC25a40 and DBF4 did 
not show reduction in expression. Numbers above each sample correspond to dilutions 
used for semi-quantitative analysis of the 1/10 dilution used to compare the two samples. 
NTC, no template control. PCR Primer sequences are indicated in Table 2. 
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Table 2. The sequences of all primer sets used for PCR, RT-PCR and qPCR 
 
The indicated positions of the primers are positions relative to the ATG sequence of DBF4 (with 
“A” as +1). “V” indicates a mixture of primers containing any nucleotide that is not T in that 
position. 
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3.2.2 DBF4ups transcription remains constant throughout the cell cycle 
 Excess thymidine creates a negative feedback loop preventing cells from producing 
dCTP. Replication stalls as DNA polymerase no longer has a substrate to incorporate cytosine 
into nascent DNA causing a cell cycle arrest in S phase when exposed to high concentrations of 
thymidine. Cells not currently in S phase will continue through the cell cycle and stall as they 
near the next S phase. Once the excess thymidine is removed from the culture media, the 
production of dCTP resumes and cells continue through the cell cycle (Bostock et al. 1971). The 
double thymidine block involves two time periods of excess thymidine to synchronize the 
majority of cells in a population at early S phase. As shown in Figure 4, when HeLa cells are 
synchronized in the beginning of S phase by double thymidine blocks and then released into 
complete medium (0 h), they entered the G2/M phase by 6 h, and the G1 phase of the next cell 
cycle by 11 h (Figure 4). 
Using the double thymidine block-based cell synchronization, our lab previously noted that 
DBF4 expression levels were reduced in early S phase, during the period of high origin activity 
(Romero 2008). Between 0 h and 4 h after release into the cell cycle, DBF4 mRNA levels were 
low compared to the asynchronous population; however, the level increased by 5 h post-double 
thymidine block and release (Figure 5A). HeLa cells were at the G2/M phase by 6-8 h, and 
reached G1 starting at 9 h post-synchronization. To investigate the expression levels of DBF4ups 
as a function of the cell cycle, RNA samples were collected at various cell cycle time points 
(shown in Figure 5B and 5C are 1, 2, 3, 6 and 10 hour time points) and monitored by qPCR 
using primer pE. Unlike DBF4 mRNA (Figure 5A), the DBF4ups expression levels remained 
constant between the asynchronous population and all time points examined throughout the S  
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Figure 4. Cell cycle profile of synchronized HeLa cells using double thymidine block 
 
 
 
          Flow cytometry profile measuring DNA content of synchronized HeLa S3 cells after   
          double thymidine block. A large portion of cells were in the G1 phase in the asynchronous  
          (As) population without block reflecting the larger amount of time spent in the G1 phase  
          by these cells. At 0 h post-double thymidine block, only one peak is seen as cells are still  
          in the beginning of S phase. The peak migrates through the gated S phase and by 6 h the  
          majority of cells in the population contain twice the DNA content of a G1 cell. Cells  
          remain a few hours in G2/M phase and mitosis completes by 11h, where most cells can be 
          seen to have split, and are almost exclusively found in G1 phase by 14 h. 
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Figure 5. DBF4ups expression is relatively constant throughout the cell cycle 
       
                
A. Origin activity, as indicated by the solid line, was measured using the nascent strand 
abundance assay in the context of DBF4 expression levels. When origin activity is high, 
expression levels of DBF4 is reduced. Activity levels are measured in % compared to the 
asynchronous population. (Romero 2008) 
B. The levels of DBF4ups are relatively constant during S phase. Total RNA isolated at 0, 1, 
2 and 6 h post-release from HeLa cells synchronized at the G1/S border using double 
thymidine block were subjected to DIG primer extension using primer pE, followed by 
acrylamide gel electrophoresis. Shown in the -752 TSS indicated on Figure 2 for primer 
pE. L: ladder, As: asynchronous HeLa cells, ntc: no template control. 
C. The levels of DBf4ups were relatively constant throughout S phase up to early G1 of the 
next cell cycle. The experiment was carried out the same as in panel B, except with 
different time-points post-G1/S. Primer extension directed to the DBF4ups transcripts 
indicated no variation in expression levels at the indicated time points. L: ladder, As: 
asynchronous HeLa cells, ntc: no template control. 
D. Densitometry was used to measure panel C by measuring the relative mean density of 
each column using ImageJ for each time point. Asynchronous (As) population was 
normalized to 100% 
27 
 
phase after release from double thymidine-based cell-cycle arrest, however the expression level 
was reduced slightly in late M phase/early G1 (Figure 5B and 5C). 
3.2.3 DBF4ups transcripts are not transcribed by RNAP I, II and III 
As RNAP II inhibition, using α-amanitin, did not reduce the expression of the DBFups 
transcripts, the possibility that RNAP III was responsible for transcribing the DBF4ups transcripts 
was further investigated as RNAP III is also known to transcribe many lncRNAs. HeLa cells 
were treated with up to 200 µM of the RNAP III inhibitor ML-60218 over 20 h (Figure 6). 
While the RNAP III-transcribed tyrosine transfer RNA (tRNAtyr), the positive control, was 
down-regulated in the presence of the RNAP III inhibitor, DBF4ups expression remained the 
same. 
Although RNAP I is not known for transcribing ncRNAs other than most rRNAs, the 
effect of RNAP I inhibition was examined mainly because the inhibition of RNAP II and III did 
not cause any significant down-regulation of the DBF4ups transcripts. HeLa cells were treated 
with 0.04 µg/ml of actinomycin D, which inhibits transcription of RNAP I at lower 
concentrations and RNAP II at higher doses. As anticipated, the 45S rRNA which is transcribed 
by RNAP I was downregulated after 3.5 h (Figure 7). Similar to the treatment with α-amanitin, 
however, actinomycin D-treated cells resulted in a stronger DBF4ups band after 20 h treatment, 
suggesting that RNAP I, II and III were not involved in transcribing the DBF4ups lncRNAs. 
3.3 The half-life of the DBF4ups transcripts is relatively short. 
Lack of the down-regulation of DBF4ups transcription raised the question of whether 
these transcripts were transcribed by RNAP I, II or III, but down-regulation was not observed in 
the studied time frame due to these lncRNAs having a particularly long half-life. RNAs isolated 
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Figure 6. RNAP III inhibitor ML-60218 does not reduce DBF4ups expression levels 
 
 
A. HeLa cells were treated with 200 µM of RNAP III inhibitor ML-60218 for 20 h. Serial 
dilutions of untreated total RNA were included for semi-quantitative analysis of PCR 
products. When compared the 1/10 dilution of untreated RNA sample with the 1/10 
dilution of ML-60218, a reduction in expression can be seen for the RNAP III-transcribed 
tRNAtyr (top panel) while there is no effect on DBF4 pre-mRNA expression levels 
(bottom panel). ntc: no template control, DMSO: DMSO-only control 
B. Total RNA from cells treated with increasing concentrations of ML-60218 for 20 h were 
subject to primer extension using primer pE. Short (bottom panel) and long (top panel) 
exposures of the DBF4ups bands show no reduction in expression level. L: ladder 
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Figure 7. RNAP I inhibitor actinomycin D does not reduce DBF4ups expression levels 
  
        
         Total RNA isolated from HeLa cells treated with 0.04 µg/ml RNAP I-inhibitor,  
         Actinomycin D was collected 3.5 and 21 h post-treatment. 
A. PCR for the RNAP I-transcribed 45S rRNA indicated a reduction of expression level 
when compared to the 1/20 dilutions across samples. ntc: no template control, L: ladder,      
-RT: samples lacking reverse transcriptase ruling out contaminating DNA 
B. cDNA PCR-based amplification of the DBF4 pre-mRNA indicated an enrichment in 
DBF4 signal after 3.5 h and 21 h. L: ladder, -RT: samples lacking reverse transcriptase 
ruling out DNA contamination 
C. Similar to DBF4 pre-mRNA, primer extension revealed an enrichment of signal for the 
DBF4ups transcripts after 3.5 and 21 h treatment. L: ladder 
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from HeLa cells using a Click-iT RNA Nascent RNA Capture Kit (Invitrogen; Burlington, 
Ontario, Canada) were analyzed for their degradation over time to determine the half-life of the 
DBF4ups transcripts (Figure 8). Using the kit, RNA was tagged with ethynyl uridine (EU), a 
uracil analogue, which incorporates into the RNA of exposed cells as the RNA is being 
synthesized. EU-labeled RNA can be selectively isolated using a Click-iT RNA Nascent RNA 
Capture Kit. EU was first added to the cell medium to allow cells the time to take up EU and 
incorporate it into the RNA being synthesized. After a period of 12 h or 24 h, EU was removed 
from the culture medium by substituting it with fresh medium. EU-labeled RNA may degrade 
over time, from which the half-life of transcripts can be determined. Transcripts containing EU at 
T0, the time at which EU was removed from the medium, were compared against the incubation 
timepoints after T0. RNA that is less stable will deplete from the pool of EU-labeled at a faster 
rate. The half-life of the DBF4ups transcript was calculated to be approximately 3.7 h while the 
half-lives of the low-turnover control RN18S and the high-turnover control UBC were calculated 
to be 14 h and 4.4 h respectively. The high turnover of DBF4ups suggests that the reduction in 
expression level would have been observed within the 20 h treatment time frame if RNAP I, II or 
III were responsible for the transcription of DBF4ups RNA. 
 
3.4 Knockdown of MtRPOL using siRNA reduces the expression of DBF4ups RNA 
While RNAP I, II and III were able to be directly inhibited with inhibitors that 
compromised each of the RNA polymerases ability to transcribe their targets, there are no well-
known inhibitors of MtRPOL. While MtRPOL activity inhibition has been recently reported to 
be an off-target effect of antiviral nucleosides (AVRNs) (Arnold et al. 2012), we have not been 
able to inhibit MtRPOL using AVRNs. I therefore attempted to ablate MtRPOL activity using  
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Figure 8. The DBF4ups transcripts have a relatively short half-life 
 
 
 
 
 
 
 
 
 
 
 
 
 
The rate of RNA degradation was monitored on labeled RNA using a Click-iT RNA Capture Kit. 
HeLa cells were incubated in medium containing ethynyl uridine (EU) for 24h. Levels of labeled 
RNA from samples collected 0 h after release into fresh medium in the absence of EU (EU-) and 
used as the pre-degradation baseline. The fold decrease between 0 h and 12 h (A) or 0 h and 24 h 
(B) post-release into EU- medium were measured. The differences in expression levels compared 
to the 0 h time point were measured using qPCR with primers for the stable 18S rRNA (low 
turnover control), ubiquitin ligase C (UBC, a transcript that has a relatively short half-life) and 
DBF4ups. While the labeled 18S rRNA showed little loss in both time points, the levels of 
DBF4ups transcripts decreased substantially, suggesting that the DBF4ups half-life is much shorter. 
standard deviation is indicated in A. 
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Figure 9. siRNA-mediated MtRPOL knockdown may affect DBF4ups expression levels 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
A. Expression levels of multiple gene transcripts were measured using RT-qPCR for 
HEK293T cells transfected with MtRPOL siRNA for 72 h. The RNA coding for the 
ribosomal protein RPS28 was used as a control to assure even concentrations between 
samples. Expression level is normalized to 100% expression being non-treated, treated 
cells were also normalized to differences in RPS28. 
B. Western blot with an antibody directed towards MtRPOL confirms the knockdown of the 
protein at 72 h post-siRNA transfection, note that DBF4 and CRM1 (loading control) 
levels remain unaffected. Untrans: untransfected control, Scram: transfected with a 
random siRNA, RNAi: MtRPOL-directed RNAi treated cells. 
C. Flow cytometry 72 h after transfection indicates a reduction in the G2/M peak as well as 
sub-G1 accumulation indicating cell death. 
A 
B 
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RNAi. By 72 h of inhibition with siRNA (Figure 9), the levels of both MtRPOL and DBF4ups 
were reduced by 72h post-treatment with siRNA. This suggests that DBF4ups may be transcribed 
by MtRPOL (figure 9A). Unexpectedly, however, the levels of DBF4 (primer C7UC) and 
SLC25a40 were also substantially downregulated (Figure 9A). DBF4ups expression was reduced 
even more drastically than the mitochondrial ND1 gene, which could be due to the considerably 
short half-life for DBFups determined previously (Figure 8). Alternatively, this result could 
indicate that the expression of DBF4 and SLC25a40 were directly affected by the expression of 
DBF4ups, perhaps by regulating the chromatin structure. 
 
3.5 No α-amanitin-resistant lncRNAs were found at the DBF4 pseudogene 
 Although the regions immediately upstream of the DBF4 transcribed region and the 
DBF4 pseudogene are unique for each chromosome, there is always the possibility that some of 
the primers used that target within the first exon of DBF4 could also be picking up signals from 
the DBF4 pseudogene, obscuring the results. While most of the primers used target within the 
DBF4 promoter region, the DIG-labeled primers pA and pC target sequences within the first 
exon of DBF4 and have high sequence similarity with the pseudogene. To assess whether these 
DIG-label primers may be picking up signals from the DBF4 pseudogene transcripts, primer 
extension was carried out on total RNA isolated from HeLa cells using three DIG-labeled 
primers targeting immediately upstream of the DBF4 pseudogene (Figure 10). 
 A product of approximately 300 bases in size was detected using the DIG-labeled primer 
ch10b (Figure 10A), which would effectively place its TSS at -209 bases from the pseudogene’s 
“ATG” sequence in the antisense direction. A faint smear of bands were also obtained with ch10a 
between -850 and beyond -1200 base in the sense direction. Unlike the DBF4ups and DBF4as 
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Figure 10. The DBF4 pseudogene has very low transcription activity 
 
 
 
A. Primer extension was used to detect lncRNA TSSs immediately upstream of the DBF4 
pseudogene locus in the absence (-α) or presence (+α) of α-amanitin. Primer ch10a was 
designed to target potential transcripts in a sense direction to the DBF4 pseudogene while 
primers ch10b and ch10c target potential lncRNAs that are antisense to the pseudogene. 
Very little signal was produced in this region with only one strongly defined band (-209 
from ATG sequence of the pseudogene). However, the observed signals were sensitive to 
α-amanitin, unlike the DBF4 promoter region. L: molecular weight marker, n: no 
template control 
B. A map of the DBF4 pseudogene on chromosome 10. The regions corresponding to each 
individual exon of the original gene have been delimited and numbered with exon 11 
notably missing. The positions of the DIG-labelled primers used in A have also been 
indicated with the position of the 5’ end of the primer indicated in relation of the ATG 
sequence of the pseudogene with the position of the -209 band indicated in A. 
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lncRNAs detected previously, all of the signals observed using the primers directed to the 
upstream region of the DBF4 pseudogene were sensitive to α-amanitin treatment. Furthermore, 
none of these signals corresponded to the TSSs of the lncRNAs previously detected using 
primers pA and pC. We can therefore rule out that the results from the previous experiment are 
not misrepresented due to the presence of the DBF4 pseudogene.  
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4.0 Discussion 
 
4.1 LncRNAs of the DBF4 locus 
The results from primer extension indicate that the multiple DBF4ups transcripts are at a 
minimum length of 200 to 450 bases long. Although the shortest lncRNA was under 100 bases in 
size, the Qiagen RNeasy mini kit isolates RNA that are over 200 bases long indicating the 
template from which it was extended is likely longer than 200 bases. The results of primer 
extension only reveal that there is a product of a certain size originating from the site and the 
direction that the DIG-labeled primer is targeting. This method does not yield a definitive 
sequence and, therefore, does not account for possible transcript splicing. The longest lncRNA 
indicated by the DIG-labeled primer pE (which targets -402) is approximately 450 bases long, 
indicating an unspliced sequence would end at -852.  
Splicing of RNA is most prominent in RNAP II-dependent transcripts and is 
accomplished with the help of a protein-RNA complex known as the spliceosome (Martins et al. 
2011). Other forms of splicing are present but are very rare and have only been identified in a 
handful of genes. Rybozymes in plant organelles, simple eukaryotes and bacteria have self-
splicing introns group II splicing with splice sites similar to those spliced by the spliceosome 
(Brown et al. 2014), however, these have not been reported in mammals. Yeast tRNAs have also 
been reported to undergo an unrelated form of protein-mediated splicing (Trotta et al. 1997). 
While self-splicing introns have been reported in yeast mitochondrial RNA, human 
mitochondrial RNA are completely devoid of intronic regions and thus no splicing may take 
place. To assess potential splicing of the DBF4 lncRNAs, the NNSPLICE human splice site 
prediction tool was used for the -402 to -852 sequence. A possible splicing acceptor site (score 
0.85) was predicted at position -666 indicating that there is a possibility that the longest of the 
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detected RNAs could be spliced. Two primer sets used in PCR, Prom 7B and Prom C7UC, also 
successfully detected the α-amanitin-resistant transcripts in this region and were able to amplify 
regions -625 to -675 and      -640 to -703, respectively. Detection of the lncRNAs using these 
PCR primers suggests that the DBF4ups transcripts are not spliced because the -666 acceptor site 
is located within the amplified PCR product. The DBF4as transcripts show 3 putative acceptor 
sites on NNSPLICE analysis. These potential splice sites have not been confirmed, however, and 
further research is needed to verify if these sites are functional splicing sites. 
Attempts to determine the remaining 3’ end of the DBF4ups sequence have so far been 
unsuccessful. Expressed sequence tags (ESTs) databases consist of randomly sequenced 
incomplete RNA fragments. ESTs are generally thought to be RNAP II transcribed mRNA as 
they are sequenced by creating cDNAs from their poly-adenosine tails (Adams et al. 1991). 
Interestingly, the DBF4ups transcripts were also present in samples isolated for polyadenylated 
RNA (unpublished data) indicating that these transcripts have a poly-A tail and may also be 
detected in EST libraries.  While a few ESTs indicates there is some noise between the DBF4 and 
SLC25a40 genes, very little information on the full sequence of the DBF4ups transcripts are 
present in online sequence browsers. Technical limitations make it difficult to perform genome-
wide studies to search for RNAP I and III transcripts as many of the genome-wide sequencing 
techniques rely on targeting capped transcripts to acquire the 5’ ends of the RNA to either target 
specific RNAP II transcripts or to filter out all of the RNA that is currently undergoing RNAse 
degradation in the sample (Kodzius et al. 2006). Other techniques simply sequence all RNA 
indiscriminately making it difficult to differentiate overlapping transcripts (Martin & Wang 
2011). The capping enzyme complex (CEC) which is responsible for capping nascent transcripts 
associates uniquely with RNA polymerase II (Cho et al. 1997).  If the DBF4ups and DBF4as 
38 
 
transcripts are not transcribed by RNA polymerase II, they are not likely capped and therefore 
may evade most mass sequencing techniques 
As previously noted, the DBF4ups transcripts were found to have poly-A tails. In 
mammals, only two types of transcripts typically contain poly-A tails: long poly-A tails are found 
on RNA transcribed by RNAP II and shorter tails on those transcribed by the mitochondrial 
RNAP (Nagaike et al. 2008).  Additionally, the TRAMP complex has been reported to 
polyadenylate ncRNA with a short series of adenosines and marking them for degradation, 
although it is not known if this process is also present in human cells (Hamill et al. 2010; 
Callahan & Butler 2010). 
A reduction in the expression of the RNAP II-transcribed SLC25a40 was an unexpected 
result that occurred during siRNA-mediated inhibition of MtRPOL (Figure 9A). Flow cytometry 
analysis of these samples also indicated a significant level of cell death (Figure 9C). It is 
possible that knockdown of MtRPOL is too toxic to the cell and the observed changes are side 
effects of dying cells in which RNA begins degrading rapidly. Alternatively, because SLC25a40 
itself codes for a mitochondrial solute carrier protein, it is possible that knockdown of MtRPOL 
caused feedback from the mitochondria for cells to reduce transcription of some mitochondria-
related proteins. While the general trend has been that the cells that were not expressing 
MtRPOL had reduced DBF4ups expression. 
 While current data on the DBF4 lncRNAs support the possibility  that MtRPOL 
transcribes these transcripts in the nucleus, I have been unable to verify the existence of the 
reported nuclear form of MtRPOL as described previously (Kravchenko et al. 2005). A recent 
study also claimed that MtRPOL does not transcribe nuclear genes or localize to the nucleus 
(Kühl et al. 2014), indicating that further research is necessary to determine the elusive source of 
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the transcription of DBF4 lncRNAs. Furthermore, even if MtRPOL located to the nucleus, it is 
still unclear which transcription factors would be required for MtRPOL to interact with 
chromosomal DNA. It is not known if MtRPOL would be able to navigate around histones as 
these proteins are absent in mitochondrial DNA (Alexeyev et al. 2013). In the mitochondria, 
MtRPOL requires transcription factors A and B2 (TFAM and TFB2M) to be able to load onto 
DNA. TFB2M has not been reported to localize in the nucleus while one study reported TFAM 
can be localized in the nucleus of human prostate PC3 cells (Pastukh et al. 2007). Alternatively, 
a nuclear MtRPOL may be interacting with proteins normally located in the nucleus. 
 
4.2 Features of the DBF4 promoter chromatin landscape 
Transcription of the DBF4ups lncRNAs begins at many sites close to the two replication 
initiation zones where the ORCs bind (Figure 1). While some transcripts have been shown to 
initiate further downstream of the DBF4 promoter region, these transcripts showed sensitivity to 
RNAP II inhibition, suggesting that they are not part of the same set of transcripts. Interestingly, 
asymmetric replication at each initiation zone proceeds in the same direction as the lncRNAs that 
begin transcription in each zone. 
Considering their proximity to replication origins, one of the possible functions of these 
lncRNAs may be their involvement in the regulation of physical access of the replication 
proteins to the location of the replication origins. Crosstalk between transcription and replication 
has been previously reported as a large set of replication origins are co-localized to active gene 
loci (Méchali 2010).  The firing of early replication origins is correlated with origins located at 
heavily transcribed regions, while late-firing origins are often located in regions with little to no 
transcription activity (Schwaiger & Schübeler 2006). While it is not known exactly what 
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determines the timing of a replication origin, it has been suggested that open chromatin 
configurations can be affected by the transcription machinery in these areas by opening up the 
region of densely packed heterochromatin to allow for easier access for replication proteins 
(Rhind 2006). It is possible that transcription of the DBF4 lncRNAs contribute to opening up the 
chromatin to allow for the ORCs to bind. A previous study suggests that ORC binding could be 
RNA dependent. Therefore, the DBF4 lncRNAs could alternatively play a role in stabilizing 
ORCs (Norseen et al. 2008). Further research is required to be able to determine the exact 
mechanism by which lncRNAs at DBF4 may be involved in the regulation of the DBF4 origin. 
While DBF4 mRNA levels fluctuate throughout the S phase, the DBF4ups transcripts 
remain constant (Fig. 5). Many genes with neighboring lncRNAs are reported to coordinate 
transcription with each other, possibly due to overlapping transcription and competition for 
transcription factors (Hiratani et al. 2009). The decrease in DBF4ups, DBF4 and SLC25a40 in 
Figure 9 could suggest that the absence of DBF4ups may have altered the chromatin landscape at 
the DBF4 promoter locus and influenced DBF4 and SLC25A40. The DBF4ups transcription 
appears to be regulated by a novel mechanism potentially involving MtRPOL as inhibiting all 
known nuclear RNA polymerases has no effect on DBFups transcript levels. The lack of 
consensus on whether or not the mitochondrial RNA polymerase is able to locate to the nucleus 
however stresses a need for more rigorous experiments to determine if MtRPOL is responsible 
for transcribing the DBF4 lncRNAs. 
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Conclusion 
In this thesis, I identify a novel lncRNAs located near the DBF4 promoter region that 
does not appear to behave like other known nuclear RNAs in terms of transcription. The first 
objective was to determine if the DBF4 lncRNAs were transcriptionally different from the DBF4 
gene with which they overlap. The DBFups transcripts are differentially transcribed from the 
DBF4 gene throughout the cell cycle and, unlike DBF4, are resistant to α-amanitin treatment. 
DBF4ups transcripts also have a half-life of approximately 3.7 h. 
It is still unclear as to which polymerase is responsible for transcribing the DBF4 
promoter region to generate the lncRNAs. Inhibiting RNA polymerases I, II and III yielded no 
apparent reduction in expression and in some cases the lncRNAs signal became stronger. 
MtRPOL is currently the strongest candidate for transcribing the DBF4 lncRNAs, although there 
are conflicting reports on whether or not it localizes to in the nucleus (Kühl et al. 2014; Lee et al. 
2011; Kravchenko et al. 2005). With the doubt surrounding whether or not MtRPOL, or a 
truncated form of the polymerase, locates to the nucleus, further research is required to confirm 
if MtRPOL is transcribing the lncRNAs discussed in this thesis. 
Lastly, in an attempt to determine if reduced transcription of the DBF4ups transcripts had 
an effect on DBF4, MtRPOL was knocked down. While knockdown of MtRPOL Yielded 
significantly reduced levels of DBF4ups transcripts, it also similarly affected the SLC25a40 gene 
and lowered levels of DBF4 as well. It is unclear if the reduction is a result of reduction of 
DB4ups transcription in the area making the promoter region for these two genes less accessible 
or if it was due to the toxicity invoked on cells as a consequence of knocking down MtRPOL. 
Finding a siRNA that is able to specifically knock down the DBF4 lncRNAs may yield more 
specific results. 
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The positioning of these lncRNAs make them an attractive target to investigate the 
complex relations between origin activity, gene transcription and lncRNA transcription at a 
single genomic locus. Further study on this aspect can open up an exciting new opportunity of 
unravelling a novel mechanism of DNA replication by lncRNA transcription in the context of 
MtRPOL-mediated transcription. 
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